Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
  2. Zhu, Bin; Xiao, Yanzi; Yeager,Meredith; Clifford, Gary; Wentzensen, Nicolas; Cullen,Michael; Boland,Joseph; Bass,Sara; Steinberg,Mia; Raine-Bennett, Tina; Lee, DongHyuk; Burk, Robert D; Pinheiro, Maisa; Song,Lei; Dean, Michael; Nelson, Chase W; Burdett,Laurie; Yu, Kai; Roberson, David; Lorey, Thomas; Franceschi, Silvia; Castle, Philip E; Walker, Joan; Zuna, Rosemary; Schiffman, Mark; Mirabello, Lisa
  3. Nature communications. 2020, Feb 14; 11(1): pii: 10.1038/s41467-020-14730-1.
  1. 2.   A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo
  2. Hancock, C. N.; Stockwin, L. H.; Han, B. N.; Divelbiss, R. D.; Jun, J. H.; Malhotra, S. V.; Hollingshead, M. G.; Newton, D. L.
  3. Free Radical Biology and Medicine. 2011, Jan; 50(1): 110-121.
  1. 3.   Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
  2. Dauner, J. G.; Pan, Y. J.; Hildesheim, A.; Harro, C.; Pinto, L. A.
  3. Vaccine. 2010, Jul; 28(33): 5407-5413.
  1. 4.   Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area
  2. Nunez-Troconis, J.; Delgado, M.; Gonzalez, J.; Mindiola, R.; Velasquez, J.; Conde, B.; Whitby, D.; Munroe, D. J.
  3. Investigacion Clinica. 2009 50(2): 203-212.
  1. 5.   Human papillomavirus false positive cytological diagnosis in low grade squamous intraepithelial lesion
  2. Nunez-Troconis, J.; Delgado, M.; Gonzalez, J.; Velasquez, J.; Mindiola, R.; Whitby, D.; Conde, B.; Munroe, D. J.
  3. Investigacion Clinica. 2009 50(4): 447-454.
  1. 6.   Oral Human Papillomavirus Infection Before and After Treatment for Human Papillomavirus 16-Positive and Human Papillomavirus 16-Negative Head and Neck Squamous Cell Carcinoma
  2. Agrawal, Y.; Koch, W. M.; Xiao, W.; Westra, W. H.; Trivett, A. L.; Symer, D. E.; Gillison, M. L.
  3. Clinical Cancer Research. 2008 14(21): 7143-7150.
  1. 7.   Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens
  2. Castle, P. E.; Sadorra, M.; Garcia, F. A. R.; Cullen, A. P.; Lorincz, A. T.; Mitchell, A. L.; Whitby, D.; Chuke, R.; Kornegay, J. R.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Apr; 16(4): 840-843.
  1. 8.   Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins
  2. Baleja, J. D.; Cherry, J. J.; Liu, Z. G.; Gao, H.; Nicklaus, M. C.; Voigt, J. H.; Chen, J. J.; Androphy, E. J.
  3. Antiviral Research. 2006, Oct; 72(1): 49-59.
  1. 9.   Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles
  2. Pinto, L. A.; Viscidi, R.; Harro, C. D.; Kemp, T. J.; Garcia-Pineres, A. J.; Trivett, M.; Demuth, F.; Lowy, D. R.; Schiller, J. T.; Berzofsky, J. A.; Hildesheim, A.
  3. Virology. 2006, Sep; 353(2): 451-462.
  1. 10.   Human alpha-defensins block papillomavirus infection
  2. Buck, C. B.; Day, P. M.; Thompson, C. D.; Lubkowski, J.; Lu, W. Y.; Lowy, D. R.; Schiller, J. T.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 31; 103(5): 1516-1521.
  1. 11.   Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma
  2. Kovacic, M. B.; Martin, M.; Gao, X. J.; Fuksenko, T.; Chen, C. J.; Cheng, Y. J.; Chen, J. Y.; Apple, R.; Hildesheim, A.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 1): 2673-2677.
  1. 12.   Human leukocyte antigen class I and II haplotypes and risk of cervical cancer
  2. Carreon, J. D.; Martin, M. P.; Hildesheim, A.; Gao, X.; Schiffman, M.; Herrero, R.; Bratti, M. C.; Sherman, M. E.; Zaino, R. J.; Carrington, M.; Wang, S. S.
  3. Tissue Antigens. 2005, OCT; 66(4): 321-324.
  1. 13.   Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Kimura, T.; Fujita, M.; Nakashima, R.; Ueda, Y.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Tanigami, A.; Yoshino, K.; Murata, Y.
  3. Cancer Research. 2005, OCT 1; 65(19): 8640-8645.
  1. 14.   Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Ueda, Y.; Fujita, M.; Nakashima, R.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Kimura, T.; Yoshino, K.; Murata, Y.
  3. Cancer Letters. 2004, SEP 15; 213(1): 31-37.
  1. 15.   Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles
  2. Pinto, L. A.; Edwards, J.; Castle, P. E.; Harro, C. D.; Lowy, D. R.; Schiller, J. T.; Wallace, D.; Kopp, W.; Adelsberger, J. W.; Baseler, M. W.; Berzofsky, J. A.; Hildesheim, A.
  3. Journal of Infectious Diseases. 2003 188(2): 327-338.
  1. 16.   A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
  2. Marin, M. C.; Jost, C. A.; Brooks, L. A.; Irwin, M. S.; O'Nions, J.; Tidy, J. A.; James, N.; McGregor, J. M.; Harwood, C. A.; Yulug, I. G.; Vousden, K. H.; Allday, M. J.; Gusterson, B.; Ikawa, S.; Hinds, P. W.; Crook, T.; Kaelin, W. G.
  3. Nature Genetics. 2000 25(1): 47-54.
  1. 17.   Interlaboratory Agreement Among Results of Human Papillomavirus Type 16 Enzyme-Linked Immunosorbent Assays
  2. Strickler, H. D.; Hildesheim, A.; Viscidi, R. P.; Shah, K. V.; Goebel, B.; Drummond, J.; Waters, D.; Sun, Y. P.; Hubbert, N. L.; Wacholder, S.; Brinton, L. A.; Han, C. L.; Nasca, P. C.; McClimens, R.; Turk, K.; Devairakkam, V.; Leitman, S.; Martin, C.; Schiller, J. T.
  3. Journal of Clinical Microbiology. 1997 35(7): 1751-1756.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel